2026-08-11
Recap: Q2 2026
Novartis Returns to Growth, Then Tells You Five Points of It Reverse in the Second Half
2026-04-29
Recap: Q1 2026
Novartis Misses in the Exact Shape It Guided, While Net Debt Adds $16 Billion in Ninety Days
2026-02-05
Recap: Q4 2025
Novartis Clears the 40% Margin Bar Two Years Early, Then Guides to Its First Core Profit Decline in Five Years
2025-10-29
Recap: Q3 2025
The Cliff Arrives: Novartis Decelerates From 21% to 7%, Then Tells the Street Its 2026 Numbers Are Too High